Comments on: In Their Own Words: A Few Pharma CEOs Chat http://www.pharmalot.com/2008/10/in-their-own-words-a-few-pharma-ceos-chat/ News, Comment and Conversation Fri, 10 Feb 2012 21:30:32 +0000 http://wordpress.org/?v=2.6.2 By: Doc http://www.pharmalot.com/2008/10/in-their-own-words-a-few-pharma-ceos-chat/#comment-380130 Doc Sun, 02 Nov 2008 21:41:04 +0000 http://www.pharmalot.com/?p=17143#comment-380130 Let's hope BMS R&D does better than Vanlev and Pargluva. Apixiban looks weak too. Let’s hope BMS R&D does better than Vanlev and Pargluva. Apixiban looks weak too.

]]> By: Someone http://www.pharmalot.com/2008/10/in-their-own-words-a-few-pharma-ceos-chat/#comment-380084 Someone Sun, 02 Nov 2008 14:42:32 +0000 http://www.pharmalot.com/?p=17143#comment-380084 Hey Jim at BMS, We hope you continue to work closely with patient groups who can help you make sure that the drugs you back to bring to the market get approved, or fast-tracked through the FDA. We are particularly thinking about BMS 214622. We understand BMS and you have made it your personal responsibility to bring this drug to market and potentially cure CML. This was just what we needed to hear to restore our faith in this industry. Especially at this difficult financially stressful times. Just when patients in North America ar increasingly finding it hard to pay for their drugs. The prospect that they will have some relief (cure?)is quite encouraging. We ARE counting on you, and we know if anyone knows how to do it, it would be you! Hey Jim at BMS,

We hope you continue to work closely with patient groups who can help you make sure that the drugs you back to bring to the market get approved, or fast-tracked through the FDA.

We are particularly thinking about BMS 214622.

We understand BMS and you have made it your personal responsibility to bring this drug to market and potentially cure CML.

This was just what we needed to hear to restore our faith in this industry. Especially at this difficult financially stressful times. Just when patients in North America ar increasingly finding it hard to pay for their drugs. The prospect that they will have some relief (cure?)is quite encouraging.

We ARE counting on you, and we know if anyone knows how to do it, it would be you!

]]> By: Jim http://www.pharmalot.com/2008/10/in-their-own-words-a-few-pharma-ceos-chat/#comment-379859 Jim Fri, 31 Oct 2008 19:47:04 +0000 http://www.pharmalot.com/?p=17143#comment-379859 The problem is the FDA is only approving 18 to 20 drugs a year!!!! This self absorbed, self important group cannot see beyond their noses. Pfizer's CEO's statement that we have to earn the trust of the public is pure crap; if they wanted to earn the publics trust EVERY trial report for their drugs would be published. If they were ethical there would be no need for the legislation introduced by Senator Grassley. The problem is the FDA is only approving 18 to 20 drugs a year!!!!

This self absorbed, self important group cannot see beyond their noses. Pfizer’s CEO’s statement that we have to earn the trust of the public is pure crap; if they wanted to earn the publics trust EVERY trial report for their drugs would be published.

If they were ethical there would be no need for the legislation introduced by Senator Grassley.

]]> By: SP http://www.pharmalot.com/2008/10/in-their-own-words-a-few-pharma-ceos-chat/#comment-379847 SP Fri, 31 Oct 2008 18:34:40 +0000 http://www.pharmalot.com/?p=17143#comment-379847 Thank God they didn't interview Fred Hassan, aka Fred Hasbeen! Thank God they didn’t interview Fred Hassan, aka Fred Hasbeen!

]]> By: Outside the Box http://www.pharmalot.com/2008/10/in-their-own-words-a-few-pharma-ceos-chat/#comment-379840 Outside the Box Fri, 31 Oct 2008 17:38:27 +0000 http://www.pharmalot.com/?p=17143#comment-379840 Pieces like this from BW are very frustrating. On the one hand you have a group of the most senior industry executives answering pertinent questions that relate to the entire industry. On the other hand their answers are at best non-specific and at worst vacuous. I truly hope (for the sake of all the employees at these companies) that the real thinking that these gentlemen bring to the table is being cleverly concealed behind the answers given to BW. If these answers really represent the depth and breadth of their thought then we need to be looking elsewhere for industry leadership, because there doesn't seem to be an original thought between them. Pieces like this from BW are very frustrating. On the one hand you have a group of the most senior industry executives answering pertinent questions that relate to the entire industry. On the other hand their answers are at best non-specific and at worst vacuous. I truly hope (for the sake of all the employees at these companies) that the real thinking that these gentlemen bring to the table is being cleverly concealed behind the answers given to BW. If these answers really represent the depth and breadth of their thought then we need to be looking elsewhere for industry leadership, because there doesn’t seem to be an original thought between them.

]]>